Quyen Thi Dao-Haddock - 17 Nov 2022 Form 4 Insider Report for BIOCEPT INC

Role
Director
Signature
/s/ Quyen Thi Dao-Haddock
Issuer symbol
N/A
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
18 Nov 2022, 19:26:29 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 17 Nov 2022 Common Stock 10,000 $0.8100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares subject to the option shall vest on each of November 17, 2023, November 17, 2024, and November 17, 2025.